{"id":5277,"date":"2025-05-05T11:12:22","date_gmt":"2025-05-05T02:12:22","guid":{"rendered":"https:\/\/dev.rftcjapan.org\/?p=5277"},"modified":"2026-02-26T15:00:51","modified_gmt":"2026-02-26T06:00:51","slug":"thank-you-epivax","status":"publish","type":"post","link":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/","title":{"rendered":"Thank You EpiVax!"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Dr. Agatsuma was the Head of Research and a member of the Executive Committee at Daiichi Sankyo. He was the innovator that led a team of researchers to develop Antibody Drug Conjugate (ADC) technology, including ADC against HER2, a critical cancer target for Breast Cancer. In other words, his ability to identify effective ways to attack cancer has contributed to better survival rates for breast cancer (and other cancers), not only in Japan, but everywhere in the world.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This donation is a significant way to remember his positive influence on science and his colleagues.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pioneer Dr. Agatsuma revolutionized cancer treatment globally through his groundbreaking development of targeted ADC technology.<\/p>\n","protected":false},"author":2,"featured_media":6903,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[],"class_list":["post-5277","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Thank You EpiVax! - RFTC Japan<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thank You EpiVax! - RFTC Japan\" \/>\n<meta property=\"og:description\" content=\"Pioneer Dr. Agatsuma revolutionized cancer treatment globally through his groundbreaking development of targeted ADC technology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/\" \/>\n<meta property=\"og:site_name\" content=\"RFTC Japan\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-05T02:12:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-26T06:00:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rftcjapan.org\/wpdata\/wp-content\/uploads\/2025\/05\/EpiVax-En.png\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"540\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Victor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Victor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/news\\\/thank-you-epivax\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/news\\\/thank-you-epivax\\\/\"},\"author\":{\"name\":\"Victor\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/#\\\/schema\\\/person\\\/d1ae48e66b6b929fa50a4630d1908812\"},\"headline\":\"Thank You EpiVax!\",\"datePublished\":\"2025-05-05T02:12:22+00:00\",\"dateModified\":\"2026-02-26T06:00:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/news\\\/thank-you-epivax\\\/\"},\"wordCount\":97,\"image\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/news\\\/thank-you-epivax\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/rftcjapan.org\\\/wpdata\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/EpiVax-En.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/news\\\/thank-you-epivax\\\/\",\"url\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/news\\\/thank-you-epivax\\\/\",\"name\":\"Thank You EpiVax! - RFTC Japan\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/news\\\/thank-you-epivax\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/news\\\/thank-you-epivax\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/rftcjapan.org\\\/wpdata\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/EpiVax-En.png\",\"datePublished\":\"2025-05-05T02:12:22+00:00\",\"dateModified\":\"2026-02-26T06:00:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/#\\\/schema\\\/person\\\/d1ae48e66b6b929fa50a4630d1908812\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/news\\\/thank-you-epivax\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/rftcjapan.org\\\/en\\\/news\\\/thank-you-epivax\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/news\\\/thank-you-epivax\\\/#primaryimage\",\"url\":\"https:\\\/\\\/rftcjapan.org\\\/wpdata\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/EpiVax-En.png\",\"contentUrl\":\"https:\\\/\\\/rftcjapan.org\\\/wpdata\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/EpiVax-En.png\",\"width\":960,\"height\":540},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/news\\\/thank-you-epivax\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/rftcjapan.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thank You EpiVax!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/#website\",\"url\":\"https:\\\/\\\/rftcjapan.org\\\/\",\"name\":\"RFTC Japan\",\"description\":\"Japan&#039;s Leading Breast Cancer Foundation\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/rftcjapan.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/#\\\/schema\\\/person\\\/d1ae48e66b6b929fa50a4630d1908812\",\"name\":\"Victor\",\"url\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/author\\\/victor\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Thank You EpiVax! - RFTC Japan","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/","og_locale":"en_US","og_type":"article","og_title":"Thank You EpiVax! - RFTC Japan","og_description":"Pioneer Dr. Agatsuma revolutionized cancer treatment globally through his groundbreaking development of targeted ADC technology.","og_url":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/","og_site_name":"RFTC Japan","article_published_time":"2025-05-05T02:12:22+00:00","article_modified_time":"2026-02-26T06:00:51+00:00","og_image":[{"width":960,"height":540,"url":"https:\/\/rftcjapan.org\/wpdata\/wp-content\/uploads\/2025\/05\/EpiVax-En.png","type":"image\/png"}],"author":"Victor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Victor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/#article","isPartOf":{"@id":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/"},"author":{"name":"Victor","@id":"https:\/\/rftcjapan.org\/#\/schema\/person\/d1ae48e66b6b929fa50a4630d1908812"},"headline":"Thank You EpiVax!","datePublished":"2025-05-05T02:12:22+00:00","dateModified":"2026-02-26T06:00:51+00:00","mainEntityOfPage":{"@id":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/"},"wordCount":97,"image":{"@id":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/#primaryimage"},"thumbnailUrl":"https:\/\/rftcjapan.org\/wpdata\/wp-content\/uploads\/2025\/05\/EpiVax-En.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/","url":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/","name":"Thank You EpiVax! - RFTC Japan","isPartOf":{"@id":"https:\/\/rftcjapan.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/#primaryimage"},"image":{"@id":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/#primaryimage"},"thumbnailUrl":"https:\/\/rftcjapan.org\/wpdata\/wp-content\/uploads\/2025\/05\/EpiVax-En.png","datePublished":"2025-05-05T02:12:22+00:00","dateModified":"2026-02-26T06:00:51+00:00","author":{"@id":"https:\/\/rftcjapan.org\/#\/schema\/person\/d1ae48e66b6b929fa50a4630d1908812"},"breadcrumb":{"@id":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/#primaryimage","url":"https:\/\/rftcjapan.org\/wpdata\/wp-content\/uploads\/2025\/05\/EpiVax-En.png","contentUrl":"https:\/\/rftcjapan.org\/wpdata\/wp-content\/uploads\/2025\/05\/EpiVax-En.png","width":960,"height":540},{"@type":"BreadcrumbList","@id":"https:\/\/rftcjapan.org\/en\/news\/thank-you-epivax\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rftcjapan.org\/"},{"@type":"ListItem","position":2,"name":"Thank You EpiVax!"}]},{"@type":"WebSite","@id":"https:\/\/rftcjapan.org\/#website","url":"https:\/\/rftcjapan.org\/","name":"RFTC Japan","description":"Japan&#039;s Leading Breast Cancer Foundation","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rftcjapan.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/rftcjapan.org\/#\/schema\/person\/d1ae48e66b6b929fa50a4630d1908812","name":"Victor","url":"https:\/\/rftcjapan.org\/en\/author\/victor\/"}]}},"_links":{"self":[{"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/posts\/5277","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/comments?post=5277"}],"version-history":[{"count":3,"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/posts\/5277\/revisions"}],"predecessor-version":[{"id":5303,"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/posts\/5277\/revisions\/5303"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/media\/6903"}],"wp:attachment":[{"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/media?parent=5277"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/categories?post=5277"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/tags?post=5277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}